Clover Health Investments, Corp. (CLOV)

NASDAQ: CLOV · IEX Real-Time Price · USD

1.220

+0.020 (1.67%)

At close: Jul 2, 2024, 4:00 PM

1.240

+0.020 (1.64%)

After-hours: Jul 2, 2024, 7:56 PM EDT

Clover Health Investments Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	606	464	444	1,695	6,782	-	Upgrade
Market Cap Growth	-2.96%	4.51%	-73.79%	-75.01%	-	-	Upgrade
Enterprise Value	268	233	115	1,108	6,824	-115	Upgrade
PE Ratio	-	-2.18	-1.31	-2.88	-49.73	-	Upgrade
PS Ratio	0.33	0.23	0.13	1.15	10.08	-	Upgrade
PB Ratio	2.07	1.62	1.25	3.17	-10.99	-	Upgrade
P/FCF Ratio	-2.32	-3.99	-1.53	-5.99	-56.90	-	Upgrade
P/OCF Ratio	-2.33	-4.01	-1.55	-6.00	-57.24	-	Upgrade
EV/Sales Ratio	0.14	0.11	0.03	0.75	10.14	-0.25	Upgrade
EV/EBITDA Ratio	-0.35	-1.10	-0.34	-1.90	-68.35	0.34	Upgrade
EV/EBIT Ratio	-0.35	-1.09	-0.34	-1.89	-67.97	0.34	Upgrade
EV/FCF Ratio	-0.33	-2.00	-0.40	-3.91	-57.25	0.72	Upgrade
Debt / Equity Ratio	0.01	0.02	0.02	0.05	-0.22	-0.19	Upgrade
Debt / EBITDA Ratio	-0.03	-0.02	-0.02	-0.05	-1.39	-0.27	Upgrade
Debt / FCF Ratio	-0.03	-0.04	-0.02	-0.10	-1.16	-0.57	Upgrade
Quick Ratio	1.26	1.21	1.12	1.85	0.89	1.68	Upgrade
Current Ratio	1.55	1.64	1.45	2.02	1.16	1.78	Upgrade
Asset Turnover	2.08	1.87	1.96	1.48	1.89	1.69	Upgrade
Interest Coverage	-22845.43	-30479.14	-253.74	-183.08	-2.79	-14.71	Upgrade
Return on Equity (ROE)	-52.00%	-67.60%	-81.50%	-127.80%	49.40%	73.40%	Upgrade
Return on Assets (ROA)	-18.00%	-19.70%	-19.10%	-59.00%	-38.30%	-132.80%	Upgrade
Return on Capital (ROIC)	-53.45%	-71.65%	-102.45%	-113.09%	19.36%	46.11%	Upgrade
Earnings Yield	-26.41%	-45.95%	-76.44%	-34.68%	-2.01%	-	Upgrade
FCF Yield	-28.03%	-25.08%	-65.46%	-16.70%	-1.76%	-	Upgrade
Buyback Yield / Dilution	-0.15%	-1.25%	-15.34%	-365.57%	-0.98%	-109.06%	Upgrade
Total Shareholder Return	-0.15%	-1.25%	-15.34%	-365.57%	-0.98%	-109.06%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).